The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society


Welcome/Intro
Brian J. Druker, MD
Neil P. Shah, MD, PhD
Moderated by:
Carson Jacobi, MPH

Welcome/Intro


What's New for Newly Diagnosed Patients
Brian J. Druker, MD
What's New for Newly Diagnosed Patients


What's New for Relapsed / Refractory Patients
Neil P. Shah, MD, PhD
What's New for Relapsed / Refractory Patients


Panel Discussion / Q&A
Brian J. Druker, MD
Neil P. Shah, MD, PhD
Carson Jacobi, MPH

Panel Discussion / Q&A

Main
 
Program Evaluation - Patients Only
 
CE Information and Evaluation - Healthcare Professionals Only
 
Contact Information
 
Full Transcript
 
Click to begin this presentation

This exciting Internet webcast begins with Brian J. Druker, MD, discussing the progress of CML therapy for newly diagnosed CML patients, and continues with an overview by Neil P. Shah, MD, PhD, as he reviews new therapies for relapsed/refractory CML patients. This program for patients with CML, caregivers and healthcare professionals is sponsored by The Leukemia & Lymphoma Society through an unrestricted educational grant from Novartis Oncology.




Sponsored by:
The Leukemia & Lymphoma Society


Supported by an unrestricted educational grant from:

System Requirements: This website takes advantage of the latest RealPlayer (Required). Download the Free RealPlayer here
 
        Copyright © 2010 CancerEducation.com